Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438277 · ClinicalTrials.gov registry record · Phase 4
Pain Increases After Shoulder Injection
A Phase 4 study, sponsored by Campbell Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 421
- Enrollment target
NCT05438277 is a Phase 4 study that has completed, run by Campbell Clinic. The registered enrollment target is 421 participants.
The verdict
NCT05438277, a Phase 4 study, has completed, sponsored by Campbell Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 421 participants
- Enrollment target
Study Summary
Compare FLARE reactions (increase in VAS by two or more points) in the first 48 hours following a shoulder injection.
Interventions
- DRUG Methylprednisolone (MPA)
- DRUG Triamcinolone Acetonide (TA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 421 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2022-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05438277
The ClinicalTrials.gov registry entry for NCT05438277 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 421 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Campbell Clinic, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methylprednisolone (MPA) is the first listed.
NCT05438277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05438277 about?
NCT05438277 is a clinical study titled "Pain Increases After Shoulder Injection". Compare FLARE reactions (increase in VAS by two or more points) in the first 48 hours following a shoulder injection.
What is the current status of trial NCT05438277?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 421 participants. The study started on 2020-01-01. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT05438277?
The interventions under investigation include: Methylprednisolone (MPA) (DRUG), Triamcinolone Acetonide (TA) (DRUG).
Who is sponsoring clinical trial NCT05438277?
This trial is sponsored by Campbell Clinic, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.